Using protein geometry to optimize cytotoxicity and the cytokine window of a ROR1 specific T cell engager.

Authors:
Zhou X; Geyer FK; Happel D; Takimoto J; Kolmar H and 1 more

Journal:
Front Immunol

Publication Year: 2024

DOI:
10.3389/fimmu.2024.1323049

PMCID:
PMC10917902

PMID:
38455046

View on PubMed View on PMC View Publisher
Journal Information

Journal Title: Front Immunol

Detailed journal information not available.

Publication Details

Subject Category: Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest Authors XZ, JT, and BR are employees of the company Fuse Biotherapeutics, Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Evidence found in paper:

"The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025